Guangdong Promulgated Reform Measures for Drug Bidding Transaction

In order to further reduce the high price of drugs this year, Guangdong will reform the methods of bidding on medicines! Recently, the Guangdong Provincial Department of Health issued five supporting documents for the relevant regulations (draft for soliciting opinions) for drug trade in Guangdong Province, and requested comments from the website. Today, affected by the new trend of the Guangdong Province's pharmaceutical procurement policy, the Shanghai and Shenzhen stocks pharmaceutical stocks basically showed a sharp downward trend in early trading, and many of the early strong stocks fell below the limit once.

According to the briefing, according to the provincial government's reform of the procurement model for medicines from the "government-led" to the "government-led and market-operated" reform spirit and related work arrangements, Guangdong will fully use modern electronic information technology to create the province's centralized The tripartite drug electronic trading platform has created a new model for drug transactions, such as online bidding, online trading, online payment, online financing, and online supervision, and has effectively reduced drug inflated prices through online bidding, price-based pricing, and other measures. The provinces and counties within the province and above the public medical institutions, medical insurance designated private medical institutions to apply the rules of drug trading, and encourage other private medical institutions to enter the trading platform for drug trading.

If you have any amendments, please submit it in writing (filled out in the form of a schedule and stamped with the company's official seal) before 17:30 pm on Friday (May 24) and submit it to the Guangdong Provincial Pharmaceutical Purchase Center.

Innovation: Set up "market entry price", squeeze water once entering the threshold

It is understood that trading drugs are divided into four categories: basic drug categories, medical insurance catalog categories, non-medical insurance catalog categories, low-priced drugs, and clinically necessary and difficult-to-purchase varieties. One of the features of this new rule is to set up “incoming market prices” in the two major categories of basic pharmaceutical products and medical insurance catalog products. The production enterprises will conduct online bidding. Experts believe that this is "the price of a drug is squeezed at the threshold of bidding," and it is basically implemented in accordance with the principle of "the lowest bidder".

Among them, the Medicare Catalogue Catalogue, the same manufacturer’s standard for the average bid price for all provinces (autonomous regions and municipalities directly under the Central Government) in the country (after the bid varieties are grouped, the exclusive production of the product is the lowest bid-winning price in the country) and Guangdong Province’s 2009 bid price for centralized pharmaceutical procurement. Take the low value as the market price. The ex-factory (port) price for the record of the production company is for reference by the medical institution in the drug transaction. The production company conducts online quotation bidding according to the purchase volume aggregated on the trading platform, and the lowest quotation is the trading symbol.

The basic drug types are averaged from the average price of the basic drug in the provinces (autonomous regions, municipalities directly under the Central Government) and the same price of the same manufacturer in Guangdong Province, and the average price of the basic drug in Guangdong in 2012 is taken as the average price (the lowest bid price for the exclusive product is taken after grouping). As the market price.

Reform: The two "joint procurement" methods are independently chosen by the hospital

Another new feature is the list of medical insurance products and basic pharmaceutical products. The “joint procurement, online bidding, and price-based pricing” approach is adopted. There are two types of joint procurement that are independently selected by each medical institution.

The first method is "trading platform to aggregate purchases according to rules and regulations." Each medical institution shall fill out the purchasing quantity of the selected product regulations on the trading platform within the specified time. The trading platform will automatically summarize the purchasing quantity reported by the medical institutions of the province each month according to the rules and regulations, and publish the aggregate purchase quantity to the enterprise. The second way is "medical organizations autonomously perform group purchases." The medical institutions will form a consortium on their own. The medical institutions will report the purchase volume of the selected product regulations on the trading platform within the specified time. The trading platform will aggregate the reported purchase volume according to the consortium and publish the consolidated purchase volume to the enterprise.

In accordance with the new regulations, on the last working day of each month, the provincial medical institutions' selection rules and the total amount of procurements for each item will be published on the website. Each related production company will quote on the system according to the announced purchase volume, and the quoted price shall not be higher than Market price. The quotation is divided into three times and completed within one day. The first time no quotation can not participate in the follow-up quotation. After each quotation is completed, the trading platform automatically prompts each manufacturer's quotation ranking (only to see the ranking of the manufacturer). When the quotation is modified, it is required that the latter quotation is lower than the previous one, and if it is not modified, the quotation will not be required again.

Market price adjustments are negotiated by the hospital through the trading platform

Previously, drug procurement was criticized in two points: First, "heavy price, light quality," and second, "low-priced old drugs are not willing to produce."

The person in charge of the Guangdong Provincial Department of Health stated that these two issues are indeed fully taken into consideration. The first is that all medical insurance catalogs adopt online bidding methods to divide and group quality levels. The government pricing varieties determine the quality level according to the current effective maximum retail price of drugs, and are classified into patents, original research, separate pricing, high-quality premiums (including differential pricing), and GMP five categories. This ensures that different levels and different quality drugs have different price assessment standards.

Second, low-priced medicines and clinically necessary and difficult-to-purchase varieties include a few emergency medicines (including human blood albumin, anti-venom serum and other blood products), and cheap general medicines (according to the latest medical insurance catalog, the average daily use cost is ≤3 yuan). , Specific clinical drug use, controlled drugs (including narcotic drugs subject to special management by the State, first class and second class psychoactive drugs, medical radiation drugs, and toxic drugs for medical use) or drugs that are designated by the State, etc. Specific specifications and regulations are announced separately. Directly selected by medical institutions to manufacturers and product specifications, the market price of government-priced varieties is the transaction price, no bid, no bargaining; market-regulated price varieties are negotiated by medical institutions through trading platforms, and online transactions are implemented.